Theodore James JrWashburn Net Worth & Insider Trades

Theodore James JrWashburn - Principal Accounting Officer, Agios Pharmaceuticals, Inc

As of March 3, 2022

What is Theodore James JrWashburn's Net Worth?

The current estimated net worth of Agios Pharmaceuticals, Inc's Principal Accounting Officer, Theodore James JrWashburn, is estimated to be about $82.08K . Theodore James JrWashburn owns about 2,549 units of Agios Pharmaceuticals, Inc common stock. In the last month at Agios Pharmaceuticals, Inc, Theodore James JrWashburn has sold an estimated value of $40.34K worth.

What is Theodore James JrWashburn's Past Insider Trading?

Theodore James JrWashburn's largest sale order was 631 units , worth over $19.62K on February 16, 2022. In total, Theodore James JrWashburn has made about 6 transactions over a month of their time at Agios Pharmaceuticals, Inc. Theodore James JrWashburn usually trades in February, with the busiest year in 2022. The most recent transaction was a sale order of 108 units , worth over $3.24K on March 1, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Theodore James JrWashburn's' Mailing Address?

  • Mailing address is C/o Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 MA

Agios Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jacqualyn A. Fouse, Ph.D. 2020 $746,750 - $1,751,340 $4,593,651 $509,657 $10,577 $7,611,975
Jacqualyn A. Fouse, Ph.D. 2019 $664,583 - $2,538,474 $12,875,608 $424,125 $105,204 $16,607,994
Jacqualyn A. Fouse, Ph.D. 2018 - - - - - - -
Jonathan Biller 2020 $500,000 - - - $258,750 $10,578 $769,328
Jonathan Biller 2019 $39,583 $110,000 $1,008,334 $2,025,036 - $936 $3,183,889
Jonathan Biller 2017 - - - - - - -
Christopher Bowden, M.D. 2020 $515,007 - $618,120 $1,508,875 $243,341 $9,203 $2,894,546
Christopher Bowden, M.D. 2019 $490,539 - $915,590 $1,609,989 $198,668 $12,422 $3,227,208
Christopher Bowden, M.D. 2018 $467,141 - $641,025 $1,746,517 $262,767 $11,280 $3,128,730
Bruce Car, Ph.D. 2020 $494,318 - $833,301 $1,499,943 $236,250 $164,231 $3,228,043
Bruce Car, Ph.D. 2019 - - - - - - -
Bruce Car, Ph.D. 2018 - - - - - - -
Andrew Hirsch 2020 $361,234 - $618,120 $1,508,875 - $397,893 $2,886,122
Andrew Hirsch 2019 $500,476 - $1,923,145 $1,609,989 $202,693 $12,528 $4,248,831
Andrew Hirsch 2018 $471,329 - $641,025 $1,746,517 $265,123 $12,864 $3,136,858
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm

What are Agios Pharmaceuticals, Inc's Past Insider Trades?

Agios Pharmaceuticals, Inc's most recent insider trade came on March 1, 2022 by Theodore James JrWashburn who sold 108 units worth $3.24K . In the last 9 years, insiders at Agios Pharmaceuticals, Inc have sold an estimated value of $169.32M and bought an estimated value of $171.9M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Scott Biller, Chief Scientific Officer,  David Schenkein, Director,  and John Duncan Higgons, Chief Operating Officer .

AGIOS PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1